0.861
3.76%
-0.0336
Xtant Medical Holdings Inc stock is currently priced at $0.861, with a 24-hour trading volume of 27,669.
It has seen a -3.76% decreased in the last 24 hours and a -16.41% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.9149 pivot point. If it approaches the $0.8449 support level, significant changes may occur.
Previous Close:
$0.8946
Open:
$0.89
24h Volume:
27,669
Market Cap:
$112.12M
Revenue:
$78.46M
Net Income/Loss:
$2.75M
P/E Ratio:
-9.5667
EPS:
-0.09
Net Cash Flow:
$-12.42M
1W Performance:
-3.26%
1M Performance:
-16.41%
6M Performance:
-26.41%
1Y Performance:
+38.87%
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Name
Xtant Medical Holdings Inc
Sector
Industry
Phone
406-388-0480
Address
664 Cruiser Lane, Belgrade, MT
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-15-18 | Reiterated | Maxim Group | Buy |
Feb-14-18 | Reiterated | Maxim Group | Buy |
Xtant Medical Holdings Inc Stock (XTNT) Latest News
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds
GlobeNewswire Inc.
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
GlobeNewswire Inc.
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
GlobeNewswire Inc.
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
GlobeNewswire Inc.
Xtant Medical to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Xtant Medical Holdings Inc Stock (XTNT) Financials Data
Xtant Medical Holdings Inc (XTNT) Revenue 2024
XTNT reported a revenue (TTM) of $78.46 million for the quarter ending September 30, 2023, a +38.46% rise year-over-year.
Xtant Medical Holdings Inc (XTNT) Net Income 2024
XTNT net income (TTM) was $2.75 million for the quarter ending September 30, 2023, a +132.18% increase year-over-year.
Xtant Medical Holdings Inc (XTNT) Cash Flow 2024
XTNT recorded a free cash flow (TTM) of -$12.42 million for the quarter ending September 30, 2023, a -171.44% decrease year-over-year.
Xtant Medical Holdings Inc (XTNT) Earnings per Share 2024
XTNT earnings per share (TTM) was $0.01 for the quarter ending September 30, 2023, a +109.09% growth year-over-year.
About Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Cap:
|
Volume (24h):